Open Label Randomized Clinical Study to Promote a Healthy Lifestyle in Medical Students
NCT ID: NCT05073029
Last Updated: 2021-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2019-02-10
2019-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Probiotic Co-administration With Omega-3 Fatty Acids on Obesity Parameters and Insulin Resistance
NCT04201938
Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study
NCT06433310
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study)
NCT05770076
Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain
NCT03368105
Efficacy of Bifidobacterium Lactis CCT 7858 in Adults Using Antibiotics
NCT04742322
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard care group
3-month course of individually selected nutrition program developed by a gastroenterologist-nutritionist and modification of physical activity (8000-10000 steps daily)
nutrition program and modification of physical activity
nutrition program developed by a gastroenterologist-nutritionist and modification of physical activity (8000-10000 steps daily)
intervention group
additionally to previous group recieved treatment with synbiotic (Fructooligosaccharides+Lactobacillus rhamnosus GG ATCC 53103) and vitamin D3 - 2000 IU. The students were instructed to take vitamin D3 and synbiotic sachets twice a day for 3 months.
synbiotic (Fructooligosaccharides+Lactobacillus rhamnosus GG ATCC 53103, 4.0х109 colony forming units - CFU)
one synbiotic sachet (3g), BID, for 3 month traetment
vitamin D3
vitamin D3, oral, 2000IU BID, for 3 month treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nutrition program and modification of physical activity
nutrition program developed by a gastroenterologist-nutritionist and modification of physical activity (8000-10000 steps daily)
synbiotic (Fructooligosaccharides+Lactobacillus rhamnosus GG ATCC 53103, 4.0х109 colony forming units - CFU)
one synbiotic sachet (3g), BID, for 3 month traetment
vitamin D3
vitamin D3, oral, 2000IU BID, for 3 month treatment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* presence of presence of vitamin D deficiency or insuficiency (serum total vit D3 level less than );
* signed informed consent.
Exclusion Criteria
* previously diagnosed allergy to gut microbiota-based therapy; gastrointestinal disorders including food allergy, gluten-sensitive enteropathy, ulcerative colitis;
* suffering from any psychiatric illness; presence of diabetes mellitus, chronic cardiovascular or respiratory disease, an active malignant tumor or chronic infections; participation in another clinical trial;
* pregnancy or lactation;
* any condition thought to be associated with poor compliance (e.g., alcoholism or drug addiction) or any condition or circumstance that would, in the opinion of the investigator, prevent completion of the study or interfere with analysis of study results.
18 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taras Shevchenko National University of Kyiv
OTHER
Bogomolets National Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nazarii Kobyliak
Associate Professor, Endocrinology Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nataliia Molochek, PhD
Role: STUDY_DIRECTOR
ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv
Liudmyla Ostapchenko, Professor
Role: STUDY_CHAIR
ESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bogomolets National Medical University
Kyiv, , Ukraine
Taras Shevchenko National University of Kyiv
Kyiv, , Ukraine
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ENDO-7
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.